(Date:12/1/2009)... A new clinical study presented to the American S...dimensional (3-D) automated ultrasound follicle me... vitro fertilization (IVF) cycle is effective and ... of the follicles. , Gurn...rtility Center of Chicago has just completed resea...
(Date:12/1/2009)... The two humanitarian organizations will collabor...biomedical repair technologies. Their shared effor...country of Togo. , Dallas...igning of a Memorandum of Understanding, Mercy Shi...rtnership to help develop sustainable infrastructu...
(Date:12/1/2009)... iCardiac now provides services to three out of t... Rochester, NY (PRWEB) December ...eader in advanced cardiac core lab services and QT...eutical company has selected iCardiac as a preferr... provide Highly Automated QT(sm) and Dynamic QT be...
(Date:12/1/2009)... California waste-to-energy firm claims first pla...ration, smallest footprint, salable pure gas, bypr... (PRWEB) December 15, 2009 -- The f...ive organic waste-to-energy process will take plac...ary. , , ,This biowaste process known as VRAD&cop...
Breaking Biology Technology:Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2First Public Showing of Innovative Waste-to-Energy Process 2...4 Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ...g,developing and commercializing proprietary produ...setting, announced today that the company,s,Presid...mpany,s corporate,overview at the following invest...cialty Pharmaceuticals Conference at the South...
...nues - a record $35.5 million vs. $24.7 million in...43.4%, Q2 2008 Diluted Net Income per Share - $0... increase of 62.5% Q2 2008 Operating Inco...New Bookings of $49.0 million vs. $34.5 million in...gy,Inc. (eRT), (Nasdaq: ERES ), a leading provide...
...., Aug. 4 Telik, Inc.,(Nasdaq: TELK ) announced ...ebcast will be held on Monday, August 11, 2008 at ...llowing the release earlier that day of the,compan... June 30, 2008., The conference call will be acce...m or by telephone at 800-553-5260 or 612-332-0720...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008 2eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9siPORTer™-96 Electroporation Chamber from Ambion
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
Rat Anti-Mouse CXCR3 Monoclonal Antibody, Allophycocyanin Conjugated, Clone 220803 from R&D Systems
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
Biology Products: